Comerica Securities,Inc. Novo Nordisk A S Transaction History

Comerica Securities,Inc.

$1.2 Billion
Q3 2023

A detailed history of Comerica Securities,Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Comerica Securities,Inc. holds 6,504 shares of NVO stock, worth $568,254. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,504

Previous 3,807 70.84%

Holding current value

$568,254

Previous $616,000 4.06%

% of portfolio

0.05%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$90.94 - $199.54 $245,265 - $538,159	2,697 Added 70.84%	6,504 $591,000
Q2 2023 Aug 04, 2023	SELL	$155.98 - $172.65 $36,499 - $40,400	-234 Reduced 5.79%	3,807 $616,000
Q1 2023 Apr 27, 2023	SELL	$132.34 - $159.14 $53,597 - $64,451	-405 Reduced 9.11%	4,041 $643,000
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $83,065 - $109,617	-810 Reduced 15.41%	4,446 $601,000
Q3 2022 Nov 07, 2022	SELL	$95.28 - $116.93 $76,319 - $93,660	-801 Reduced 13.22%	5,256 $524,000
Q2 2022 Jul 19, 2022	BUY	$103.24 - $121.81 $177,263 - $209,147	1,717 Added 39.56%	6,057 $675,000
Q1 2022 Apr 28, 2022	BUY	$93.1 - $112.54 $65,821 - $79,565	707 Added 19.46%	4,340 $486,000
Q4 2021 Feb 10, 2022	SELL	$95.88 - $117.08 $57,144 - $69,779	-596 Reduced 14.09%	3,633 $407,000
Q3 2021 Nov 10, 2021	SELL	$84.42 - $106.62 $10,552 - $13,327	-125 Reduced 2.87%	4,229 $406,000
Q2 2021 Aug 11, 2021	SELL	$67.66 - $84.76 $78,350 - $98,152	-1,158 Reduced 21.01%	4,354 $365,000
Q1 2021 May 12, 2021	SELL	$67.06 - $75.82 $38,425 - $43,444	-573 Reduced 9.42%	5,512 $377,000
Q4 2020 Feb 09, 2021	SELL	$63.89 - $73.8 $12,330 - $14,243	-193 Reduced 3.07%	6,085 $425,000
Q3 2020 Nov 04, 2020	SELL	$63.69 - $70.22 $13,438 - $14,816	-211 Reduced 3.25%	6,278 $436,000
Q2 2020 Jul 17, 2020	SELL	$58.54 - $67.94 $91,615 - $106,326	-1,565 Reduced 19.43%	6,489 $425,000
Q1 2020 Apr 16, 2020	BUY	$49.46 - $64.78 $4,500 - $5,894	91 Added 1.14%	8,054 $484,000
Q4 2019 Feb 11, 2020	SELL	$49.86 - $58.26 $8,526 - $9,962	-171 Reduced 2.1%	7,963 $461,000
Q3 2019 Oct 15, 2019	SELL	$47.54 - $53.43 $157,309 - $176,799	-3,309 Reduced 28.92%	8,134 $421,000
Q3 2019 Oct 15, 2019	BUY	$47.54 - $53.43 $153,506 - $172,525	3,229 Added 39.31%	11,443 $527,000
Q2 2019 Aug 09, 2019	BUY	$46.79 - $52.47 $10,621 - $11,910	227 Added 2.84%	8,214 $419,000
Q1 2019 May 07, 2019	BUY	$46.36 - $52.63 $370,277 - $420,355	7,987 New	7,987 $422,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comerica Securities,Inc. with notifications on news.

Account

Comerica Securities,Inc. Novo Nordisk A S Transaction History